All sites C00-96,D32-33,D42-43,D45-47,D76 257 87.1 4.8 3.8 0.9 3.3
Mouth, pharynx C00-14 4 100.0 - - - -
  Lip C00 2 100.0 - - - -
  Tongue C02 0 100.0 - - - -
  Mouth, other C03-06 1 100.0 - - - -
  Salivary glands C07-08 1 100.0 - - - -
  Pharynx C01,C09-14 1 100.0 - - - -
Digestive organs C15-26 50 85.5 3.2 6.0 0.8 4.4
  Oesophagus C15 4 100.0 - - - -
  Stomach C16 7 94.3 - - - 5.7
  Small intestine C17 1 100.0 - - - -
  Colon C18 10 96.2 - 1.9 - 1.9
  Rectum, rectosigmoid C19-20 9 97.7 - 2.3 - -
  Anus C21 0 100.0 - - - -
  Liver C22 6 86.2 - 10.3 - 3.4
  Gallbladder, bile ducts C23-24 1 83.3 16.7 - - -
  Pancreas C25 11 53.7 13.0 18.5 3.7 11.1
  Other digestive organs C26 1 66.7 - - - 33.3
Respiratory organs C30-39 39 62.2 17.3 11.7 2.6 6.1
  Nose, sinuses C30-31 0 100.0 - - - -
  Larynx, epiglottis C32 2 90.0 10.0 - - -
  Lung, trachea C33-34 37 60.7 18.0 12.0 2.7 6.6
  Mediastinum, pleura C38 0 100.0 - - - -
Bone C40-41 - - - - - -
Melanoma of the skin C43 7 100.0 - - - -
Skin, non-melanoma C44 15 100.0 - - - -
Mesothelioma C45 0 100.0 - - - -
Autonomic nervous system C47 0 100.0 - - - -
Soft tissues C48-49 1 85.7 14.3 - - -
Breast C50 0 100.0 - - - -
Male genital organs C60-63 73 99.2 - 0.3 0.5 -
  Prostate C61 71 99.2 - 0.3 0.6 -
  Testis C62 1 100.0 - - - -
  Other male genital C60,C63 1 100.0 - - - -
Urinary organs C64-68 24 96.6 0.8 - 0.8 1.7
  Kidney C64 11 96.5 1.8 - 1.8 -
  Bladder and urinary tract2 C65-68 12 96.7 - - - 3.3
Eye C69 1 66.7 - - 33.3 -
Brain, central nervous system C70-72,D32-33,D42-43 6 86.2 - 6.9 - 6.9
Thyroid gland C73 3 100.0 - - - -
Other endocrine glands C74-75 - - - - - -
Illdefined or unknown C76,C80 6 53.3 13.3 16.7 3.3 13.3
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 26 78.8 10.6 2.3 - 8.3
  Hodgkin lymphoma C81 1 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 11 100.0 - - - -
  Malignant immunoproliferative diseases C88 1 100.0 - - - -
  Myeloma and other plasma cell tumors C90 5 59.3 18.5 7.4 - 14.8
  Leukaemia C91-95 4 85.7 4.8 4.8 - 4.8
  Myelodysplastic syndromes D46 1 28.6 28.6 - - 42.9
  Myeloproliferaitive neoplasms D45,D47 2 18.2 54.5 - - 27.3
Not included above
  Basal cell carcinoma of the skin 60 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.